Morning Overview on MSN
The first cellular age-reversal therapy has been cleared for human trials
Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...
A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...
HOUSTON, JULY 1, 2026 ― A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...
Signal transduction and gene regulation are at the heart of cell and developmental biology, driving cell fate decisions and tissue homeostasis. In cancer, ...
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.
The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a prescription that will make you 10 years younger. Now MIT Technology Review has ...
Researchers from Sichuan University developed a mineralized DNA hydrogel scaffold that regulates immune responses while sustaining calcium-driven bone regeneration for improved healing of skeletal ...
Researchers developed a mineralized DNA hydrogel that coordinates immune regulation and sustained bone regeneration for complex skeletal defects CHENGDU, SICHUAN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results